Quick-Med Technologies Appoints Paul H. Jenssen as Its Chief Financial Officer
15 Janeiro 2013 - 8:01PM
Marketwired
GAINESVILLE, FL--(Marketwire -
January 15, 2013) - Quick-Med Technologies, Inc. (OTCQB: QMDT)
announced today that its Board of Directors (the "Board") appointed
Paul H. Jenssen as the Company's Chief Financial Officer and
corporate secretary, effective as of January 10, 2013. He replaces
Nam H. Nguyen, whom Quick-Med wishes to thank for his contributions
and years of service, and who will provide active support for the
transition.
Mr. Jenssen has 35 years of experience in strategic planning,
process improvement, finance and accounting. He started his career
at Deloitte Touche (1978-1984) before becoming Treasurer at
Associated Press (1984-1998). In addition to working as a
consultant since 1998, he was the CFO, COO and a Senior Managing
Director at Rothschild North America investment bank (1998-2006).
He is a CPA, has an MBA with highest honors from Columbia
University in New York and has held several securities licenses. He
is also an engaged member of the community and has worked in
several teaching positions. Additional information can be
found in the Company's current report on Form 8-K filed with the
Securities and Exchange Commission and available on the Company's
website.
"We are very excited to have Paul join our team at Quick-Med, as
he brings terrific experiences to support our operational and
investment needs. This completes the centralization of our
operations to our Gainesville site, and will improve and simplify
our ability to communicate with our clients and investors as a
team" stated Bernd Liesenfeld, President of Quick-Med.
About Quick-Med Technolgies,
Inc. Quick-Med Technologies, Inc. is a life sciences company
that is developing innovative technologies for the healthcare and
consumer markets. Quick-Med is developing NIMBUS® and NimbuDerm™ applications in
several advanced medical device formats including wound care
dressings, adhesives, medical grade thermoplastics, and skin
sanitizers. NIMBUS is the FDA-cleared technology that has been
commercialized in a line of wound dressings. The Company's
MultiStat® compounds are
commercialized in skin care products. The company is also
commercializing its Stay
Fresh™ technology for
apparel and other textile applications. For more information, see:
www.quickmedtech.com.
© 2013 Quick-Med Technologies, Inc. All rights reserved.
NIMBUS® and
MultiStat® are registered
trademarks and NimbuDerm™ and Stay
Fresh™ are trademarks of Quick-Med Technologies, Inc.
Forward-looking statements
(statements which are not historical facts) in this release are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. For this purpose, any
statements contained in this release that are not statements of
historical fact may be deemed to be forward-looking statements.
Without limiting the generality of the foregoing, words such as
"may," "will," "to," "expect," "plan," "believe," "anticipate,"
"intend," "could," "would," "estimate," and/or "continue" or the
negative or other variations thereof or comparable terminology are
intended to identify forward-looking statements involve risks and
uncertainties, including those risks that are discussed in the
Company's filings with the Securities and Exchange Commission
("SEC"), which may be accessed at the SEC's Edgar System at
www.sec.gov.
Contact: Bernd Liesenfeld President Tel: (888) 835-2211 x103
Email: bliesenfeld@quickmedtech.com
Quick Med Technologies (CE) (USOTC:QMDT)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Quick Med Technologies (CE) (USOTC:QMDT)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
